247 related articles for article (PubMed ID: 22033631)
21. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract][Full Text] [Related]
22. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
Jo YS; Li S; Song JH; Kwon KH; Lee JC; Rha SY; Lee HJ; Sul JY; Kweon GR; Ro HK; Kim JM; Shong M
J Clin Endocrinol Metab; 2006 Sep; 91(9):3667-70. PubMed ID: 16772349
[TBL] [Abstract][Full Text] [Related]
23. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
Kim MH; Bae JS; Lim DJ; Lee H; Jeon SR; Park GS; Jung CK
Endocr Relat Cancer; 2014; 21(6):891-902. PubMed ID: 25266729
[TBL] [Abstract][Full Text] [Related]
24. The prevalence and prognostic value of BRAF mutation in thyroid cancer.
Kebebew E; Weng J; Bauer J; Ranvier G; Clark OH; Duh QY; Shibru D; Bastian B; Griffin A
Ann Surg; 2007 Sep; 246(3):466-70; discussion 470-1. PubMed ID: 17717450
[TBL] [Abstract][Full Text] [Related]
25. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
[TBL] [Abstract][Full Text] [Related]
26. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.
Kwak JY; Kim EK; Kim JK; Han JH; Hong SW; Park TS; Choi JR
Head Neck; 2010 Apr; 32(4):490-8. PubMed ID: 19672964
[TBL] [Abstract][Full Text] [Related]
27. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.
Kim TY; Kim WB; Song JY; Rhee YS; Gong G; Cho YM; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2005 Nov; 63(5):588-93. PubMed ID: 16268813
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.
Oler G; Cerutti JM
Cancer; 2009 Mar; 115(5):972-80. PubMed ID: 19152441
[TBL] [Abstract][Full Text] [Related]
29. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
Lupi C; Giannini R; Ugolini C; Proietti A; Berti P; Minuto M; Materazzi G; Elisei R; Santoro M; Miccoli P; Basolo F
J Clin Endocrinol Metab; 2007 Nov; 92(11):4085-90. PubMed ID: 17785355
[TBL] [Abstract][Full Text] [Related]
30. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.
Baitei EY; Zou M; Al-Mohanna F; Collison K; Alzahrani AS; Farid NR; Meyer B; Shi Y
J Pathol; 2009 Apr; 217(5):707-15. PubMed ID: 19156774
[TBL] [Abstract][Full Text] [Related]
31. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT
Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.
Kim J; Giuliano AE; Turner RR; Gaffney RE; Umetani N; Kitago M; Elashoff D; Hoon DS
Ann Surg; 2006 Nov; 244(5):799-804. PubMed ID: 17060774
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry.
McKelvie PA; Chan F; Yu Y; Waring P; Gresshoff I; Farrell S; Williams RA
Pathology; 2013 Dec; 45(7):637-44. PubMed ID: 24247620
[TBL] [Abstract][Full Text] [Related]
34. Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study.
Mathur A; Moses W; Rahbari R; Khanafshar E; Duh QY; Clark O; Kebebew E
Cancer; 2011 Oct; 117(19):4390-5. PubMed ID: 21412762
[TBL] [Abstract][Full Text] [Related]
35. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
Park AY; Son EJ; Kim JA; Youk JH; Park YJ; Park CS; Chang HS
PLoS One; 2014; 9(10):e110868. PubMed ID: 25337709
[TBL] [Abstract][Full Text] [Related]
36. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
[TBL] [Abstract][Full Text] [Related]
37. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose.
Takahashi K; Eguchi H; Arihiro K; Ito R; Koyama K; Soda M; Cologne J; Hayashi Y; Nakata Y; Nakachi K; Hamatani K
Mol Carcinog; 2007 Mar; 46(3):242-8. PubMed ID: 17186541
[TBL] [Abstract][Full Text] [Related]
38. Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.
Park SY; Park YJ; Lee YJ; Lee HS; Choi SH; Choe G; Jang HC; Park SH; Park DJ; Cho BY
Cancer; 2006 Oct; 107(8):1831-8. PubMed ID: 16983703
[TBL] [Abstract][Full Text] [Related]
39. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
40. [BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].
Cañadas Garre M; López de la Torre Casares M; Becerra Massare P; López Nevot MÁ; Villar Del Moral J; Muñoz Pérez N; Vílchez Joya R; Montes Ramírez R; Llamas Elvira JM
Endocrinol Nutr; 2011 Apr; 58(4):175-84. PubMed ID: 21441079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
